Navigation Links
A Milestone of Opportunity for VNUS Medical Technologies
Date:6/8/2009

Over Half a Million Varicose Vein Patients Treated with VNUS Closure Procedure Worldwide

SAN JOSE, Calif., June 8 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, the underlying cause of varicose veins, announced today that as of this week, it estimates the number of patients treated with the VNUS Closure radiofrequency vein ablation system has surpassed 500,000 worldwide. Thousands of physicians across the Americas, Europe and Asia have embraced the VNUS ClosureFAST(TM) catheter and ClosureRFS(TM) device as a highly effective minimally invasive medical technology for treating diseased leg veins and restoring healthy circulation to varicose vein patients.

VNUS solutions have also achieved widespread acceptance among medical insurers, with all major US health insurance insurers covering radiofrequency vein ablation for patients with symptomatic varicose veins and venous reflux. In addition, the VNUS procedure is available in 40 countries and is covered by the national health insurance systems in the UK and France.

"Achieving the physician, patient and insurer acceptance that has led to 500,000 patients treated with our VNUS Closure procedure is a tremendous milestone both for our company and for the field of minimally invasive vein treatment," said Brian E. Farley, VNUS' first employee in 1995 and President and CEO. "Although this accomplishment is notable, we expect that in the future our Closure products will ultimately help millions of patients suffering from venous reflux. We also believe that our success emanates from a strong commitment to product quality supported by clinical and comparative effectiveness trials of our products. The results of these trials have proven to the medical and payor community that the VNUS Closure catheter offers superior clinical benefits to patients compared to alternative therapies. We believe our physician customers and employees gain a deep sense of satisfaction from providing such high quality medical care and products to our most important constituents - the patients treated with VNUS Closure products."

VNUS' products have been featured in over 100 clinical publications and more than ten published book chapters. Some of the company's most significant milestones include:

  • 1995: Company founded, development of catheters using RF energy to controllably shrink veins
  • January 1998: First Closure procedure performed
  • March 1999: FDA clearance of the VNUS Closure catheter and radiofrequency generator
  • August 2003: Publication of randomized trial of the Closure catheter vs. vein stripping
  • September 2005: Publication of Closure clinical study confirming the long-term efficacy of the procedure
  • October 2005: FDA clearance of the Closure RFS device for treatment of perforator veins
  • August 2006: FDA clearance of ClosureFAST, the next-generation catheter
  • March 2007: Launch of the ClosureFAST catheter to physicians and the public
  • June 2008: VNUS licenses its patents for vein ablation to laser competitors
  • April 2009: UK National Health Service cites VNUS Closure procedure as a select innovative technology
  • May 2009: Covidien Ltd. announces intent to acquire VNUS
  • June 2009: Publication of randomized trial of the ClosureFAST catheter vs. laser ablation
  • June 2009: 500,000th Closure procedure performed.

ABOUT VNUS MEDICAL TECHNOLOGIES, INC.

Founded in 1995 and headquartered in San Jose, California, VNUS Medical Technologies (NASDAQ: VNUS) is a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is the underlying cause of varicose veins. VNUS sells the Closure system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to treat diseased veins through the application of temperature-controlled RF energy. For more information, please visit www.vnus.com.


'/>"/>
SOURCE VNUS Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
2. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
3. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
4. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
5. Smurfit-Stones Hodge, LA, Mill Becomes First to Achieve Safety Milestone
6. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
7. Milestone Scientific to Present at the Edgewater Research Investor Conference
8. Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007
9. Global Gene Map Clears New Milestone
10. Free Site Offering Patient-Physician Dialog Reaches Milestone
11. Marlo Thomas and St. Jude Childrens Research Hospital(R) Announce Hitting The 50-Partner Milestone as They Kick Off the Fourth Annual Thanks and Giving(R) Campaign Which Asks America to Support St. Jude While Shopping This Holiday Season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... New York (PRWEB) , ... February 05, 2016 , ... ... use and find themselves having to wait longer to access the treadmills. It’s a ... New Year’s resolutions to lose weight and get in shape by joining gyms, starting ...
(Date:2/5/2016)... ... , ... At its annual meeting held last week, the American Parkinson Disease ... of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We are pleased ... APDA President and CEO. “Pat has tirelessly served APDA since 2001 when he was ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Colorize ... on one drop zone to the next using Colorize's dynamic moving camera. Colorize is ... This package includes a 3D slideshow environment with 1 to 5 focus points per ...
(Date:2/5/2016)... ... 05, 2016 , ... On June 9-10, Las Vegas will ... education (CME) event presented by the Association for Comprehensive Care in Rare Diseases ... whose mission is to provide education, tools, and resources to primary care clinicians ...
(Date:2/5/2016)... Luis Obispo, CA (PRWEB) , ... February 05, 2016 , ... ... new changes that Medicare San Luis Obispo users can expect to see in 2016. ... , The two most significant changes will directly impact many San Luis Obispo seniors ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Worldwide ... achieve significant growth as next generation systems provide ... use radiology for cancer surgery. New systems pinpoint ... overdosing that has been such a problem previously, ... delivered. Radiosurgery robots take cancer surgery far beyond ...
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... and competitive market to drive long-term market growth ... very common set of chronic disorders that affect ... disparate in terms of their symptoms and key ... by dysregulation of immune pathways and an inappropriate ...
Breaking Medicine Technology: